1. Home
  2. ANGI vs KROS Comparison

ANGI vs KROS Comparison

Compare ANGI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • KROS
  • Stock Information
  • Founded
  • ANGI 1995
  • KROS 2015
  • Country
  • ANGI United States
  • KROS United States
  • Employees
  • ANGI N/A
  • KROS N/A
  • Industry
  • ANGI Advertising
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANGI Consumer Discretionary
  • KROS Health Care
  • Exchange
  • ANGI Nasdaq
  • KROS Nasdaq
  • Market Cap
  • ANGI 566.2M
  • KROS 558.9M
  • IPO Year
  • ANGI 2017
  • KROS 2020
  • Fundamental
  • Price
  • ANGI $15.97
  • KROS $14.53
  • Analyst Decision
  • ANGI Hold
  • KROS Buy
  • Analyst Count
  • ANGI 8
  • KROS 13
  • Target Price
  • ANGI $20.33
  • KROS $20.63
  • AVG Volume (30 Days)
  • ANGI 1.3M
  • KROS 477.3K
  • Earning Date
  • ANGI 08-05-2025
  • KROS 08-06-2025
  • Dividend Yield
  • ANGI N/A
  • KROS N/A
  • EPS Growth
  • ANGI N/A
  • KROS N/A
  • EPS
  • ANGI 1.03
  • KROS 0.11
  • Revenue
  • ANGI $1,125,635,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • ANGI N/A
  • KROS $5,006.76
  • Revenue Next Year
  • ANGI $4.24
  • KROS N/A
  • P/E Ratio
  • ANGI $15.48
  • KROS $132.80
  • Revenue Growth
  • ANGI N/A
  • KROS 91657.70
  • 52 Week Low
  • ANGI $10.88
  • KROS $9.12
  • 52 Week High
  • ANGI $29.15
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 50.65
  • KROS 64.67
  • Support Level
  • ANGI $16.00
  • KROS $13.26
  • Resistance Level
  • ANGI $17.13
  • KROS $14.68
  • Average True Range (ATR)
  • ANGI 0.65
  • KROS 0.41
  • MACD
  • ANGI 0.05
  • KROS 0.12
  • Stochastic Oscillator
  • ANGI 48.67
  • KROS 89.35

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: